New diabetes clinical trial: A Bridging Study of Efsubaglutide Alfa in Healthy Adults in Brazil

Published on: 2026-04-08T04:00:00Z
Conditions: Diabete Type 2
Interventions: Drug: Efsubaglutide Alfa Injection; Drug: Placebo
Sponsors: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Not yet recruiting
https://ift.tt/nHjNLx3